Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
D000367:Age Factors; D000368:Aged; D002986:Clinical Trials as Topic; D004088:Dihydroergotoxine / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy* / Q000209:etiology; D009497:Neurotic Disorders / Q000188:drug therapy* / Q000209:etiology; D013881:Thioridazine / Q000008:administration & dosage / Q000627:therapeutic use*
D004088:Dihydroergotoxine; D004877:Ergoloid Mesylates; D013881:Thioridazine